Skip to main content
x

  • PASSIONATE ABOUT
    HELPING PATIENTS
    AVOID UNNECESSARY
    SUFFERING

OUR PASSION IS PROGRESS

Neurelis is a unique central nervous system-focused company built on a foundation of passion and progress. This passion fuels our drive to continuously deliver innovative therapies that have the potential to change the lives of patients, caregivers, and healthcare providers. 

ABOUT NEURELIS

Neurelis is a neuroscience-based specialty pharmaceutical company dedicated to enhancing therapeutic benefit and addressing gaps in patient care.

OUR PIPELINE

Our pipeline currently includes NRL-1, which is being developed as an on-hand rescue therapy to control intermittent bouts of seizure activity (seizure emergencies), NRL-2, a preclinical product candidate for acute anxiety episodes or panic attacks, and NRL-3, an investigational product being developed as a non-invasive acute therapy to stop siezures that have progressed to status epilepticus.

KEEP CURRENT

Get the most up-to-date information about Neurelis and our products.

HAVE A QUESTION ABOUT NEURELIS?

Please contact us if you have any questions about Neurelis or any of the products we are currently developing. 

Contact Us